Early Detection of Chronic Kidney Disease

This retrospective observational study aims to assess the proportion of patients who were appropriately referred from primary care to the nephrology teleconsultation service. The appropriateness of the referral will be determined by the time elapsed between the referral criteria being met and the date of the teleconsultation, as well as by the patient's treatment at the time of referral.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Kidney Diseases Chronic Disease Disease Attributes Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Male Urogenital Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Renal Insufficiency Renal Insufficiency, Chronic Urogenital Diseases Urologic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Consorci Sanitari Alt Penedés-Garraf

Sant Pere de Ribes, Barcelona, 08810, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Men and women over 18 years of age
Teleconsultation to nephrology from Primary Care in the Garraf region during the period from January to December 2024
Patients with at least one referral criterion for the nephrology service

Exclusion criteria

Participants diagnosed with any of the following conditions:

Patients with Chronic Kidney Disease previously evaluated by the nephrology service.
History of requiring renal replacement therapy (hemodialysis, peritoneal dialysis, or kidney transplantation).
Patients hospitalized within the last 3 months with a diagnosis of kidney failure.
Patients with a known prior diagnosis of Autosomal Dominant Polycystic Kidney Disease or glomerular diseases.

Treatment and study plan

Primary outcomes

Appropriate referral to teleconsultation

Time frame: Baseline

Proportion of patients referred to nephrology teleconsultation during 2024 in a timely manner and with appropriate treatment. Timely referral is defined as referral within three months of the appearance of nephrology referral criteria. Treatment adequacy will be assessed based on the recommendations of the SEMERGEN Primary Care guidelines and the therapeutic harmonization protocols established by CatSalut.

Sponsors and collaborators

Lead sponsor

Consorci Sanitari de l'Alt Penedès i Garraf

Other

Registry information

Official study title

Cross-sectional Study on the Early Detection of Chronic Kidney Disease

Acronym: DetERC-GARRAF

Important dates

Study start: 2025
Primary completion: 2025
Study completion: 2025
First posted: Apr 30, 2025
Registry last updated: Dec 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed